Grover A K, Xu A, Samson S E, Narayanan N
Department of Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
Am J Physiol. 1996 Jul;271(1 Pt 1):C181-7. doi: 10.1152/ajpcell.1996.271.1.C181.
Coronary artery smooth muscle expresses an alternative splice (SERCA2b) of the sarcoplasmic reticulum (SR) Ca2+ pump gene SERCA2, which is also expressed in cardiac muscle (SERCA2a), but how the activity of this transporter is regulated in the coronary artery is not known. SERCA2a in the cardiac muscle can be regulated via phospholamban or, as recently reported, by a direct phosphorylation of this protein by calmodulin kinase (Xu, A., C. Hawkins, and N. Narayanan. J.Biol. Chem. 268:8394-8397, 1993). Because both SERCA2a and SERCA2b contain this calmodulin kinase phosphorylation site, we examined the effect of endogenous calmodulin kinase phosphorylation of the SR Ca2+ pump in the coronary artery. SR-enriched membranes were isolated from coronary artery smooth muscle and washed in ethylene glycol-bis-(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid to remove bound calmodulin. When these membranes were incubated with MgATP2- in the presence of Ca2+/calmodulin, a 115-kDa protein was phosphorylated. This phosphorylated 115-kDa protein was identified as SERCA2b in Western blots and by immunoprecipitation using a SERCA2-selective antibody. Preincubating the membranes in MgATP2- in the presence of Ca2+/calmodulin stimulated the subsequent Ca2+ uptake in the presence of oxalate plus MgATP2- and azide. The stimulation of Ca2+ uptake was inhibited by including the SR Ca2+ pump inhibitors thapsigargin and cyclopiazonic acid in the Ca2+ uptake medium or by including the calmodulin antagonist N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide or the calmodulin kinase II peptide fragment 290-309 in the phosphorylation solution. Thus an endogenous calmodulin-dependent kinase phosphorylated SERCA2b and activated it. Phospholamban could not be detected in these membranes in Western blots. Therefore, the regulation of the SR Ca2+ pump activity in coronary artery smooth muscle may involve a direct phosphorylation of the pump protein by an endogenous calmodulin-dependent kinase.
冠状动脉平滑肌表达肌浆网(SR)Ca2+泵基因SERCA2的一种可变剪接体(SERCA2b),该基因在心肌中也有表达(SERCA2a),但尚不清楚这种转运蛋白在冠状动脉中的活性是如何调节的。心肌中的SERCA2a可通过受磷蛋白进行调节,或者如最近报道的那样,通过钙调蛋白激酶对该蛋白的直接磷酸化进行调节(Xu,A.,C. Hawkins,和N. Narayanan. J.Biol. Chem. 268:8394 - 8397,1993)。由于SERCA2a和SERCA2b都含有这种钙调蛋白激酶磷酸化位点,我们研究了冠状动脉中内源性钙调蛋白激酶对SR Ca2+泵的磷酸化作用。从冠状动脉平滑肌中分离出富含SR的膜,并在乙二醇 - 双(β - 氨基乙基醚)- N,N,N',N'-四乙酸中洗涤以去除结合的钙调蛋白。当这些膜在Ca2+/钙调蛋白存在的情况下与MgATP2-一起孵育时,一种115 kDa的蛋白质被磷酸化。在蛋白质印迹法以及使用SERCA2选择性抗体进行免疫沉淀时,这种磷酸化的115 kDa蛋白质被鉴定为SERCA2b。在Ca2+/钙调蛋白存在的情况下,在MgATP2-中对膜进行预孵育,可刺激随后在草酸盐加MgATP2-和叠氮化物存在时的Ca2+摄取。在Ca2+摄取培养基中加入SR Ca2+泵抑制剂毒胡萝卜素和环匹阿尼酸,或者在磷酸化溶液中加入钙调蛋白拮抗剂N - (6 - 氨基己基)- 5 - 氯 - 1 - 萘磺酰胺或钙调蛋白激酶II肽片段290 - 309,均可抑制Ca2+摄取的刺激作用。因此,一种内源性钙调蛋白依赖性激酶使SERCA2b磷酸化并激活了它。在这些膜的蛋白质印迹法中未检测到受磷蛋白。因此,冠状动脉平滑肌中SR Ca2+泵活性的调节可能涉及一种内源性钙调蛋白依赖性激酶对泵蛋白的直接磷酸化作用。